NASDAQ:CCXI

Chemocentryx Stock Predictions

> Biotechnology

Buy CCXI

*Your capital is at risk

$10.24

+0.0150 (+0.147%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CCXI Prediction Chart

CCXI Predictions History

Latest community submissions for CCXI.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
Tim @Tim.21688	Mar 14, 2018	$12.79 -8.77%	$14.02	X	91.20%
Adi	Mar 14, 2018	$11.30 -19.40%	$14.02	X	80.60%
JS Pro	Mar 14, 2018	$12.00 -14.41%	$14.02	X	85.60%
SEAN LAVELLE	Mar 14, 2018	$0.440 -96.86%	$14.02	X	3.10%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CCXI with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CHEMOCENTRYX INC

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by